🇪🇺 BRENTUXIMAB VEDOTIN in European Union

BRENTUXIMAB VEDOTIN (BRENTUXIMAB VEDOTIN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002455
  • Local brand name: Adcetris
  • Status: approved

BRENTUXIMAB VEDOTIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BRENTUXIMAB VEDOTIN approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for BRENTUXIMAB VEDOTIN in European Union?

Marketing authorisation holder not available in our data.